Discuss treatment guidelines and recommendations for appropriate patient assessment, treatment selection, and risk stratification strategies within dyslipidemia. |
|
|
|
|
|
Analyze available and emerging dyslipidemia therapeutics, including statin therapy and PCSK9 inhibitors. |
|
|
|
|
|
Formulate personalized treatment plans to accurately assess patient-specific characteristics, optimizing therapeutic selection to improve outcomes in dyslipidemia. |
|
|
|
|
|